Comparing the Dynamics of Different HIV-1 cDNA Species in CD4-positive T-cells and HIV-1 RNA in Plasma of Infected Individuals After Initiation of Antiretroviral Therapy With or Without Raltegravir

Trial Profile

Comparing the Dynamics of Different HIV-1 cDNA Species in CD4-positive T-cells and HIV-1 RNA in Plasma of Infected Individuals After Initiation of Antiretroviral Therapy With or Without Raltegravir

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Raltegravir (Primary) ; Efavirenz; Nucleoside reverse transcriptase inhibitors; Nucleotide reverse transcriptase inhibitors; Peptide hydrolase inhibitors
  • Indications HIV-1 infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Nov 2015 Status changed from recruiting to completed as per results published in the Journal of Antimicrobial Chemotherapy
    • 04 Dec 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top